31 Aug 2017
Beximco Pharmaceuticals Limited, one of the leading pharmaceuticals company in Bangladesh, is engaged in manufacturing and marketing of generic pharmaceuticals
formulation product. We initiated a valuation based on Discounted Cash Flow method and Relative Valuation method while assuming next 5-Years’ CAGR of revenue will be 12.96%. Currently, BXPHARMA is traded at BDT 109.1. In our valuation, the target price based on DCF
and Relative Valuation is determined at BDT 128.1 per share.